Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools BIOINFORMATICS
MacroH2As regulate enhancer-promoter contacts affecting enhancer activity and sensitivity to inflammatory cytokines CELL REP
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial BLOOD
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience CANCERS
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia CANCERS
Towards a druggable epitranscriptome: Compounds that target RNA modifications in cancer BRIT J PHARMACOL
A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4(+) lymphoma cells without toxicity in immunocompromised and immunocompetent mice BIOMED PHARMACOTHER
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT (vol 57, pg 416, 2022) BONE MARROW TRANSPL
Ocular involvement in patients with primary central-nervous-system lymphoma: Analysis of a multicentre study in Spain BRIT J HAEMATOL